High metabolic tumor volume is associated with decreased efficacy of axicabtagene ciloleucel in large B-cell lymphoma

High metabolic tumor volume (MTV) predicts worse outcomes in lymphoma treated with chemotherapy. However, it is unknown if this holds for patients treated with axicabtagene ciloleucel (axi-cel), an anti-CD19 targeted chimeric antigen receptor T-cell therapy. The primary objective of this retrospecti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Dean, Erin A., Mhaskar, Rahul S., Lu, Hong, Mousa, Mina S., Krivenko, Gabriel S., Lazaryan, Aleksandr, Bachmeier, Christina A., Chavez, Julio C., Nishihori, Taiga, Davila, Marco L., Khimani, Farhad, Liu, Hien D., Pinilla-Ibarz, Javier, Shah, Bijal D., Jain, Michael D., Balagurunathan, Yoganand, Locke, Frederick L.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Lymphoid Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7391155/
https://ncbi.nlm.nih.gov/pubmed/32702097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001900
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars